Collaborative Assessment and Management of Suicidality (CAMS)
Collaborative Assessment and Management of Suicidality (CAMS) is a crisis psychotherapy developed by David Jobes in 2006. Its core mechanism: collaborative exploration of suicidal drivers (pain, stress, agitation, hopelessness, self-hate) within therapeutic framework transforms relationship to suicidality. This catalogue links it to suicidality and self-harm, typically in individual format, variable.
Related condition topics
These links support exploration. They do not establish that CAMS is effective or recommended for each condition.
How Collaborative Assessment and Management of Suicidality works
Collaborative exploration of suicidal drivers (pain, stress, agitation, hopelessness, self-hate) within therapeutic framework transforms relationship to suicidality
Ontology
Suicidality as a way of coping with psychological pain; collaborative understanding is more therapeutic than risk categorization
Therapeutic Voice
"I want to understand your pain from the inside. On a scale of 1-5, how much is psychological pain driving this right now?"
View of the Person
A suffering being whose suicidality makes sense as attempted solution to unbearable pain: collaboration reveals alternatives
Epistemology
Evidence
1 condition assessment available
An overall effectiveness assessment has not been completed. Completed assessments for specific populations appear below.
Condition-specific assessments
Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.
Suicidality & Self-Harm
Population and scope: Adults at suicide risk in the VA/DoD care context; CAMS for reducing suicidal ideation.
Guideline evidence inconclusive
VA/DoD 2024 recommendation 8 found insufficient evidence to recommend for or against CAMS for reducing suicidal ideation. This does not mean CAMS is ineffective or lacks randomized studies. The guideline describes a small pooled ideation benefit compared with alternative interventions, but no statistically clear benefit in the military/Veteran subgroup; some smaller comparisons with usual care found no differences, and study quality and modified delivery limit interpretation. It does not establish prevention of suicide deaths. VA/DoD’s evidence search ended on 15 March 2023; later studies were not reviewed in this assessment.
Source assessment dated
Guidelines and official sources (2)
1 clinical guideline check · 1 professional reference check
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- Assessment and Management of Patients at Risk for Suicide
Insufficient evidence for or against
The 2024 guideline finds insufficient evidence for or against CAMS for reducing suicidal ideation. Inclusion in the guideline is not a positive recommendation. The guideline describes a small pooled ideation benefit versus alternative interventions but no statistically clear benefit in military/Veteran samples, with limitations in study quality and delivery.
Scope: Adults aged 18 and over at risk of suicide; CAMS for reducing suicidal ideation.
- Treatment for Suicidal Ideation, Self-Harm, and Suicide Attempts Among Youth
Discussed in the source
SAMHSA describes CAMS but distinguishes assessment-tool validation from youth treatment efficacy. Its dated evidence statement should not be read as a current review of all youth trials.
Scope: Youth assessment and suicide-focused care; source published in 2020.
Recorded material under review
The existing notes below are retained separately from assessment records. These recorded claims await source checking, including study design, recommendations and numerical estimates.
5+ RCTs
Included in suicide intervention reviews
Growing evidence. Shift from risk assessment to therapeutic framework.
Training and certification
CAMS training (1-2 day workshop). SSF-based framework for suicidal clients
CAMS-care offers role-based training
8-16 hrs; proficiency: supervised cases
$300-1.5K
Equity & Cultural Adaptations
Clinical cautions and blind spots
Assessment and precautions
Active psychosis that prevents collaboration and severe cognitive impairment require assessment of the person's ability to participate and of the care and support needed. This review has not established a CAMS-specific contraindication rule based solely on involuntary admission.
Sources for the corrected statements:
Blind spots
Collaboration can require adaptation when acute symptoms or cognitive difficulties limit participation. The care plan must address the person's current safety needs; emergency assessment or hospitalization may be appropriate and should not be treated as evidence that collaboration has failed.
Sources for the corrected statements:
Philosophical roots
Shneidman (psychological pain); Jobes (suicide as problem-solving gone wrong); Rogers (collaboration over authority); phenomenology (understanding the patient's experience of suicidality)
Compared with other approaches
Test Yourself
What makes CAMS 'collaborative'?
Show answer
Clinician and patient sit side-by-side completing the SSF: shared understanding vs. top-down assessment.